| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/nar/RobinsonHHFPM15 |
| P356 | DOI | 10.1093/NAR/GKU1161 |
| P932 | PMC publication ID | 4383959 |
| P698 | PubMed publication ID | 25414341 |
| P5875 | ResearchGate publication ID | 268790759 |
| P50 | author | Steven G. E. Marsh | Q7615026 |
| James D Hayhurst | Q58000808 | ||
| Paul Flicek | Q28359506 | ||
| P2093 | author name string | James Robinson | |
| Peter Parham | |||
| Jason A Halliwell | |||
| P2860 | cites work | Modernizing reference genome assemblies | Q21145769 |
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| Nomenclature for factors of the HLA system, 2010 | Q24605855 | ||
| Fast and efficient searching of biological data resources--using EB-eye | Q24607662 | ||
| dbSNP: the NCBI database of genetic variation | Q24608672 | ||
| Improved tools for biological sequence comparison | Q24652199 | ||
| Web services at the European Bioinformatics Institute-2009 | Q24655417 | ||
| IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex | Q24681805 | ||
| Basic local alignment search tool | Q25938991 | ||
| IMGT/HLA database--a sequence database for the human major histocompatibility complex | Q28142639 | ||
| Nomenclature of human platelet antigens | Q28205492 | ||
| Real-time DNA sequencing from single polymerase molecules | Q28301519 | ||
| Nomenclature of platelet-specific antigens. | Q50703383 | ||
| Nomenclature for the major histocompatibility complexes of different species: a proposal. | Q50704256 | ||
| Nomenclature for chicken major histocompatibility (B) complex. | Q50716516 | ||
| Nomenclature for chicken MHC (B) antigens defined by monoclonal antibodies | Q50717828 | ||
| Nomenclature for factors of the dog major histocompatibility system (DLA), 2000: second report of the ISAG DLA Nomenclature Committee. | Q53322516 | ||
| The IMGT/HLA database | Q56879486 | ||
| The IMGT/HLA database | Q56879489 | ||
| The use of reference strand-mediated conformational analysis for the study of cheetah (Acinonyx jubatus) feline leucocyte antigen class II DRB polymorphisms | Q57216045 | ||
| Characterization of bovine MHC class II polymorphism using three typing methods: serology, RFLP and IEF | Q67522591 | ||
| Leukocyte antigens in cattle, sheep and goats. Nomenclature | Q70142969 | ||
| Real-time DNA sequencing from single polymerase molecules | Q84483467 | ||
| A new bioinformatics analysis tools framework at EMBL-EBI. | Q29547584 | ||
| Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion | Q29616531 | ||
| Comprehensive analysis of MHC class I genes from the U-, S-, and Z-lineages in Atlantic salmon | Q33537377 | ||
| Virtual reality in the MHC. | Q33630594 | ||
| High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array™ System for simplified amplicon library preparation. | Q34582241 | ||
| High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation | Q34582448 | ||
| The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse | Q35630854 | ||
| 2004 Nomenclature for the chicken major histocompatibility (B and Y) complex. | Q35838294 | ||
| Gene map of the extended human MHC. | Q35968433 | ||
| Nomenclature report on the major histocompatibility complex genes and alleles of Great Ape, Old and New World monkey species | Q36094968 | ||
| Nomenclature for factors of the swine leukocyte antigen class II system, 2005. | Q36321314 | ||
| Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string | Q37023945 | ||
| The European searchable tumour line database. | Q37378460 | ||
| 16(th) IHIW : review of HLA typing by NGS. | Q38072775 | ||
| ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank | Q38454585 | ||
| Cattle MHC nomenclature: is it possible to assign sequences to discrete class I genes? | Q39640787 | ||
| Human KIR sequences 2003. | Q40577433 | ||
| Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing | Q41905932 | ||
| A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep | Q44202709 | ||
| Progress of the comparative MHC Committee and a summary of the Comparative MHC Workshops held at the 32nd ISAG, Edinburgh and the 9th IVIS, Tokyo, 2010. | Q44364517 | ||
| Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. | Q47587797 | ||
| Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. | Q48236848 | ||
| Polymorphism of the class II gene of rat major histocompatibility complex, RT1: partial sequence comparison of the first domain of the RT1.B beta 1 alleles | Q48240406 | ||
| Describing structural changes by extending HGVS sequence variation nomenclature. | Q48653504 | ||
| Nomenclature for factors of the SLA system, update 2008. | Q48673179 | ||
| ISAG/IUIS-VIC Comparative MHC Nomenclature Committee report, 2005. | Q48705549 | ||
| Nomenclature for factors of the dog major histocompatibility system (DLA), 1998: first report of the ISAG DLA Nomenclature Committee | Q48752437 | ||
| A nomenclature solution to mouse MHC confusion. | Q48762004 | ||
| Leukocyte antigens of cattle and sheep. Nomenclature | Q48800114 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | Database issue | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | database | Q8513 |
| P304 | page(s) | D423-31 | |
| P577 | publication date | 2014-11-20 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | The IPD and IMGT/HLA database: allele variant databases | |
| P478 | volume | 43 |
| Q92368511 | A New Fast Phasing Method Based On Haplotype Subtraction |
| Q64118851 | A Screening Test for in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events |
| Q58764194 | A Valine Mismatch at Position 129 of Is an Independent Predictor of Cytomegalovirus Infection and Acute Kidney Rejection in Simultaneous Pancreas⁻Kidney Transplantation Recipients |
| Q37384843 | A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units. |
| Q36359688 | A gene feature enumeration approach for describing HLA allele polymorphism. |
| Q92025822 | A large peptidome dataset improves HLA class I epitope prediction across most of the human population |
| Q40689618 | A new HLA-A allele, HLA-A* 02:01:119, identified in a Chinese individual |
| Q40950109 | A new HLA-B*15 allele, HLA-B*15:263, identified in a Korean individual |
| Q47834781 | A new MICA allele, MICA*007:07, characterized by cloning and sequencing. |
| Q48313448 | A new allele, HLA-A*03:275N. |
| Q48127593 | A new allele, HLA-DQA1*02:01:02. |
| Q53644010 | A novel HLA allele, HLA-B*50:48, identified by sequencing-based typing. |
| Q54154811 | A novel HLA allele, HLA-DQB1*02:57, was identified by polymerase chain reaction sequence-based typing in a Chinese individual. |
| Q48239643 | A novel HLA class II allele, HLA-DRB1*04:01:17, identified in a Chinese volunteer donor for China Marrow Donor Program |
| Q49584851 | A novel HLA-A*02 allele, A*02:692, was identified by sequencing-based typing |
| Q53628265 | A novel HLA-A*24 allele, A*24:02:61, confirmed in a Chinese individual. |
| Q54146709 | A novel HLA-A*24 allele, HLA-A*24:325, identified in a Chinese individual. |
| Q48247937 | A novel HLA-A*26 allele, HLA-A*26:01:44, identified in a Caucasian individual |
| Q40817367 | A novel HLA-B allele, HLA-B*35:254, identified by sequence-based typing from a HIV-associated tuberculosis sufferer |
| Q51714515 | A novel HLA-B allele, HLA-B*35:279, identified by sequencing-based typing in a Czech patient. |
| Q50099332 | A novel HLA-B allele, HLA-B*35:348, was identified by sequencing-based typing |
| Q47868324 | A novel HLA-B*14 allele - B*14:53 - genetics and serology |
| Q53673884 | A novel HLA-B*18 allele, HLA-B*18:124, identified in a German volunteer bone marrow donor. |
| Q40805495 | A novel HLA-B*27 allele, B*27:138, identified by sequence-based typing |
| Q51702625 | A novel HLA-B*40 allele, B*40:01:40, identified in a Chinese individual. |
| Q53524254 | A novel HLA-C allele, HLA-C*08:128, was identified in a leukemia patient by polymerase chain reaction sequence-based typing. |
| Q40057753 | A novel HLA-C null allele, HLA-C*08:121N. |
| Q40060335 | A novel HLA-DRB1 allele, DRB1*15:66:02 was identified in a Chinese potential donor by sequence-based typing |
| Q48295878 | A novel HLA-DRB1 allele, HLA-DRB1*14:127:02, detected in a Chinese hematopoietic stem cell donor. |
| Q53792059 | A novel HLA-DRB1*04 allele, DRB1*04:01:17, was identified by sequencing-based typing. |
| Q48114443 | A novel HLA-DRB1*07 allele, HLA-DRB1*07:01:22, identified in a Chinese individual. |
| Q36020341 | A novel RNAseq-assisted method for MHC class I genotyping in a non-model species applied to a lethal vaccination-induced alloimmune disease |
| Q40057802 | A novel allele HLA-A*11:152 was identified by sequence-based typing in a Chinese individual |
| Q54140333 | A novel allele, HLA-A*33:97 was identified in a Chinese bone marrow donor. |
| Q48102965 | A novel allele, HLA-C*14:02:01:03, identified by full-length genomic sequencing. |
| Q53117434 | A variant of HLA-DRB1*11, HLA-DRB1*11:143, discovered in a Chinese hematopoietic stem cell donor. |
| Q38836848 | A web resource for mining HLA associations with adverse drug reactions: HLA-ADR |
| Q38659633 | AIDS in chimpanzees: the role of MHC genes |
| Q92816464 | ALPHLARD-NT: Bayesian Method for Human Leukocyte Antigen Genotyping and Mutation Calling through Simultaneous Analysis of Normal and Tumor Whole-Genome Sequence Data |
| Q58544658 | ALPHLARD: a Bayesian method for analyzing HLA genes from whole genome sequence data |
| Q100750316 | Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy |
| Q52721104 | Accurate Typing of Human Leukocyte Antigen Class I Genes by Oxford Nanopore Sequencing. |
| Q57489233 | Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report |
| Q93196165 | Admixture and natural selection shaped genomes of an Austronesian-speaking population in the Solomon Islands |
| Q42072504 | Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study |
| Q47703247 | Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking |
| Q60046859 | Allele-Level Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations |
| Q94475735 | Allele-level HLA matching reduces early rejection in lung transplant recipients |
| Q89748473 | Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci |
| Q90481753 | Allele-specific genome targeting in the development of precision medicine |
| Q35930689 | Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population |
| Q59223463 | AltHapAlignR: improved accuracy of RNA-seq analyses through the use of alternative haplotypes |
| Q58091281 | Amino acid signatures in the HLA class II peptide-binding region associated with protection/susceptibility to the severe West Nile Virus disease |
| Q48267133 | An HLA-B7-specific antibody in an HLA-B*07 positive patient explained by a nonexpressed allele (HLA-B*07:181N). |
| Q39155771 | An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting). |
| Q36122304 | An analytical workflow for accurate variant discovery in highly divergent regions |
| Q35731934 | An efficient algorithm for the extraction of HGVS variant descriptions from sequences |
| Q112716011 | Analysis of Genomic DNA from Medieval Plague Victims Suggests Long-Term Effect of Yersinia pestis on Human Immunity Genes |
| Q91868683 | Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands |
| Q55385543 | Ancient DNA study reveals HLA susceptibility locus for leprosy in medieval Europeans. |
| Q39225803 | Ankylosing Spondylitis: HLA-B*27-Positive Versus HLA-B*27-Negative Disease. |
| Q95658188 | Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report |
| Q37355618 | Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination |
| Q94955649 | Association of HLA-DR-DQ alleles, haplotypes, and diplotypes with Type 1 diabetes in Saudis |
| Q38569872 | Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism. |
| Q37528715 | Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation. |
| Q38922475 | BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation |
| Q55512710 | Benchmarking the HLA typing performance of Polysolver and Optitype in 50 Danish parental trios. |
| Q92963159 | Best practices for bioinformatic characterization of neoantigens for clinical utility |
| Q91956173 | Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells |
| Q91936174 | Bioinformatics Strategies, Challenges, and Opportunities for Next Generation Sequencing-Based HLA Genotyping |
| Q92239384 | Bit-parallel sequence-to-graph alignment |
| Q42342982 | Bone marrow transplant donor recruitment strategies to maximize, optimize, and equalize recipient chances of an acceptable match. |
| Q48355191 | Bonobos Maintain Immune System Diversity with Three Functional Types of MHC-B. |
| Q31034123 | Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): An integrated case-control analysis pipeline |
| Q37677332 | Bronchial Epithelial Cells from Asthmatic Patients Display Less Functional HLA-G Isoform Expression. |
| Q28383022 | CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor |
| Q92413534 | Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List? |
| Q55127614 | Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. |
| Q48273514 | Characterisation of the novel HLA-G null allele, HLA-G*01:21N, in Finnish individuals |
| Q64137220 | Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen Loci: A GeT-RM Collaborative Project |
| Q40976790 | Characterization of a new HLA allele: A*02:548. |
| Q47884609 | Characterization of a new HLA-A allele, HLA-A*02:07:08, by cloning and sequencing |
| Q48097844 | Characterization of a novel HLA-B*39:01:01-related allele, HLA-B*39:130, by cloning and phasing. |
| Q47869697 | Characterization of a novel HLA-B*40 allele, HLA-B*40:186:02, by cloning and sequencing |
| Q51714521 | Characterization of a novel MICA allele, MICA*012:05, by cloning and sequencing. |
| Q48104778 | Characterization of the novel HLA-A*02:07:10 allele by sequencing-based typing. |
| Q48273666 | Characterization of the novel HLA-B*48:43 allele by sequencing-based typing. |
| Q48328838 | Characterization of the novel HLA-B*49:39 allele identified in a German leukaemia patient |
| Q41321099 | Characterization of the novel HLA-C*08:01:09 allele identified in a Chinese Han individual |
| Q48104807 | Characterization of the novel HLA-DQB1*05:155 allele by sequencing-based typing |
| Q48121179 | Characterization of the novel HLA-DRB1*11:01:20 allele. |
| Q48103233 | Characterization of the novel HLA-DRB1*13:241 allele by sequencing-based typing. |
| Q51069048 | Characterization of three new HLA Class I Alleles in Spanish Caucasians, HLA-A*02:620, HLA-B*27:150 and HLA-B*07:05:01:02. |
| Q38534421 | Clinical Role of Human Leukocyte Antigen in Health and Disease. |
| Q47795034 | Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant |
| Q38568889 | Co-evolution of MHC class I and variable NK cell receptors in placental mammals |
| Q39013101 | Combining one-step Sanger sequencing with phasing probe hybridization for HLA class I typing yields rapid, G-group resolution predicting 99% of unique full length protein sequences |
| Q39013106 | Common and well-documented HLA alleles over all of Europe and within European sub-regions: A catalogue from the European Federation for Immunogenetics. |
| Q90433982 | Comparative MHC nomenclature: report from the ISAG/IUIS-VIC committee 2018 |
| Q45873080 | Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells. |
| Q39157730 | Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors |
| Q40711589 | Complete exon 2 sequence of the HLA-DPA1*03:01 allele by sequence-based typing |
| Q38554524 | Computer-aided design of T-cell epitope-based vaccines: addressing population coverage |
| Q36359462 | Concordance of next generation sequence-based and sequence specific oligonucleotide probe-based HLA-DRB1 genotyping |
| Q39093040 | Confirmation and next-generation sequencing of allele HLA-B*35:279 found in a family of a leukaemia patient with Western Asia origin |
| Q48280753 | Confirmation of the HLA-C*16:97 allele in multiple individuals, a new common and well-defined allele? |
| Q48329321 | Confirmed the full-length sequence of HLA-B*44:03:02 by cloning and sequencing. |
| Q47550775 | Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome |
| Q61807980 | Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates |
| Q64360303 | Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules |
| Q62682526 | Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II alleles. |
| Q48204405 | Construction of full-length Japanese reference panel of class I HLA genes with single-molecule, real-time sequencing. |
| Q30235983 | Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system |
| Q38612613 | Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity. |
| Q46341545 | Deciphering the fine nucleotide diversity of full HLA class I and class II genes in a well-documented population from sub-Saharan Africa |
| Q37622486 | Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology |
| Q88636862 | Deduced probable HLA haplotypes associated with HLA-C*04:82 found by case analysis of Taiwanese individuals |
| Q89775715 | Deduced probable human leukocyte antigen haplotypes associated with HLA-A*11:256Q and HLA-A*02:621 identified by case analyses of Taiwanese individuals |
| Q88636945 | Deduced probable human leukocyte antigen haplotypes associated with human leukocyte antigen DRB1*04:36 identified by case analysis of Taiwanese individuals |
| Q91843704 | Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV |
| Q40741464 | Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease |
| Q61443414 | DeepSeqPan, a novel deep convolutional neural network model for pan-specific class I HLA-peptide binding affinity prediction |
| Q37153103 | Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing. |
| Q90257760 | Definition of naturally processed peptides reveals convergent presentation of autoantigenic topoisomerase-I epitopes in scleroderma |
| Q48121152 | Description of a new HLA-A*02 allele, A*02:658, in a Russian individual. |
| Q48358831 | Description of the novel HLA-A allele, HLA-A*11:229, identified by sequence-based typing in a Chinese individual. |
| Q40052558 | Description of two new HLA-A alleles, HLA-A*02:572 and HLA-A*03:225. |
| Q38870681 | Design and engineering of deimmunized biotherapeutics. |
| Q90176802 | Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy |
| Q48327934 | Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells |
| Q40060350 | Detection of 549 new HLA alleles in potential stem cell donors from the United States, Poland and Germany |
| Q48241745 | Detection of a new HLA-B*44 allele, HLA-B*44:02:45, by monoallelic Sanger sequencing |
| Q48362078 | Detection of a novel HLA-A*11 variant, A*11:263, in a Taiwanese individual |
| Q48324628 | Detection of a novel HLA-B allele, HLA-B*39:119, in a Chinese individual. |
| Q48192220 | Detection of a novel HLA-C*03 variant, HLA-C*03:227, in a Taiwanese individual. |
| Q48259822 | Detection of a novel HLA-DRB1*09 variant, HLA-DRB1*09:31, in a College of American Pathologists HLA survey sample. |
| Q48290149 | Detection of a novel HLA-DRB1*12 variant, HLA-DRB1*12:67, in a Taiwanese individual. |
| Q48273468 | Detection of a novel HLA-DRB1*12 variant, HLA-DRB1*12:68, in a Taiwanese individual |
| Q53150191 | Detection of a novel allele, HLA-A*24:198, by sequence-based typing in a Chinese individual. |
| Q44038884 | Detection of the HLA-DQB1 allele, DQB1*03:82, in a Kazakh patient with acute myeloid leukemia. |
| Q89944648 | Determinants of Resistance to Checkpoint Inhibitors |
| Q64938049 | Developing pharmacogenetic screening methods for an emergent country: Vietnam. |
| Q93234175 | Development and evaluation of a transfusion medicine genome wide genotyping array |
| Q91658389 | Differences in MHC-B diversity and KIR epitopes in two populations of wild chimpanzees |
| Q51146989 | Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa. |
| Q91152146 | Differential admixture, human leukocyte antigen diversity, and hematopoietic cell transplantation in Latin America: challenges and opportunities |
| Q50099307 | Discovery of HLA-C*14:87, a novel HLA-C*14 variant, in a Taiwanese individual |
| Q48094818 | Discovery of a novel HLA-A*02 variant, HLA-A*02:684, in a Taiwanese individual. |
| Q48371381 | Discovery of a novel HLA-B*15 allele, HLA-B*15:379, in a patient from Guinea-Bissau. |
| Q47185303 | Discovery of gorilla MHC-C expressing C1 ligand for KIR. |
| Q57817936 | Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation |
| Q93360218 | Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation |
| Q40995549 | Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles |
| Q38552461 | Distribution of HLA haplotypes across Japanese Archipelago: similarity, difference and admixture |
| Q47775194 | Distribution of HLA-DQB1 in Czech Patients with Central Hypersomnias. |
| Q89075998 | Divergent Allele Advantage at Human MHC Genes: Signatures of Past and Ongoing Selection |
| Q89866149 | Diversity of HLA Class I and Class II blocks and conserved extended haplotypes in Lacandon Mayans |
| Q92657459 | Diversity of KIR, HLA Class I, and Their Interactions in Seven Populations of Sub-Saharan Africans |
| Q36376526 | Droplet Barcode Sequencing for targeted linked-read haplotyping of single DNA molecules |
| Q36382640 | Dual redundant sequencing strategy: Full-length gene characterisation of 1056 novel and confirmatory HLA alleles. |
| Q92180542 | Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes |
| Q60919455 | Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells |
| Q48153546 | Epitopes and motifs of the HLA-B*14 allele family products and related HLA-B14 cross-reactive specificities |
| Q64251507 | European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer Treatment |
| Q31140417 | Evaluation of computational programs to predict HLA genotypes from genomic sequencing data. |
| Q57025324 | Evolutionary Pressure against MHC Class II Binding Cancer Mutations |
| Q91174532 | Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy |
| Q51210573 | Exon 2 sequencing of the new HLA-DRB1 allele, DRB1*13:216. |
| Q47269061 | Experimental manipulation of population-level MHC diversity controls pathogen virulence evolution in Mus musculus. |
| Q47797670 | Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy |
| Q38666496 | Expression and phylogenetic analyses reveal paralogous lineages of putatively classical and non-classical MHC-I genes in three sparrow species (Passer). |
| Q38662456 | Extreme MHC class I diversity in the sedge warbler (Acrocephalus schoenobaenus); selection patterns and allelic divergence suggest that different genes have different functions. |
| Q52879548 | Fifty-one full-length major histocompatibility complex class II alleles in the olive baboon (Papio anubis). |
| Q53810496 | Four new HLA class I alleles in Spaniards, HLA-A*32:01:23, HLA-B*18:01:24, HLA-B*18:72:02 and HLA-C*12:166. |
| Q48290759 | Four new HLA class I alleles, HLA-A*02:681, HLA-A*30:111, HLA-A*68:164 and HLA-B*35:01:46. |
| Q38929359 | From HLA typing to anti-HLA antibody detection and beyond: The road ahead |
| Q48122152 | Full-length sequence of HLA-B*55:02:01:01, confirmed by cloning and sequencing. |
| Q48328633 | Full-length sequences of 2 HLA-B alleles, B*48:03:01 and B*48:04:01, confirmed by cloning and sequencing. |
| Q48173879 | Full-length sequences of 3 HLA-B alleles, B*07:05:01:01, B*14:01:01 and B*18:02, confirmed by cloning and sequencing |
| Q48156659 | Full-length sequences of 3 HLA-B alleles, B*40:01:01, B*40:03 and B*40:40, confirmed by cloning and sequencing. |
| Q48156571 | Full-length sequences of 3 HLA-B alleles, HLA-B*27:04:01, B*27:07:01 and B*27:25, confirmed by cloning and sequencing. |
| Q48192155 | Full-length sequences of 3 HLA-B*56 alleles, B*56:01:01:01, B*56:03 and B*56:04, confirmed by cloning and sequencing. |
| Q48173857 | Full-length sequences of 4 HLA-B*15 alleles, B*15:03:01:01, B*15:13:01, B*15:18:01:01 and B*15:25:01, confirmed by cloning and sequencing |
| Q48173781 | Full-length sequences of 4 HLA-B*15 alleles, B*15:07:01:01, B*15:27:01, B*15:32:01 and B*15:58, confirmed by cloning and sequencing. |
| Q48173815 | Full-length sequences of 4 HLA-B*35 alleles, B*35:02:01:01, B*35:03:01:01, B*35:05:01:01 and B*35:08:01:01, confirmed by cloning and sequencing |
| Q48173793 | Full-length sequences of HLA-B*67:01:01 and B*67:01:02, confirmed by cloning and sequencing. |
| Q52358306 | General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept. |
| Q52584948 | Genetic Mechanisms Involved in the Generation of HLA Alleles in Brazilians: Description and Comparison of HLA Alleles. |
| Q37194662 | Genetic Polymorphisms of TLR4 and MICA are Associated with Severity of Trachoma Disease in Tanzania |
| Q99565432 | Genetic and environmental determinants of human TCR repertoire diversity |
| Q28069956 | Genetic barriers in transplantation medicine |
| Q47344812 | Genetic polymorphism of human leucocyte antigen and susceptibility to multidrug-resistant and rifampicin-resistant tuberculosis in Han Chinese from Hubei Province. |
| Q92375512 | Genetic predisposition to celiac disease in Kazakhstan: Potential impact on the clinical practice in Central Asia |
| Q60053983 | Genetic variants influence on the placenta regulatory landscape |
| Q33589777 | Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population |
| Q92484417 | Genomic evidence for MHC disassortative mating in humans |
| Q47876430 | Genomic full-length sequence of a novel HLA-A*11:01:01:02 allele was identified in a Chinese bone marrow donor |
| Q54140324 | Genomic full-length sequence of two new HLA-C alleles, HLA-C*04:239 and HLA-C*05:137. |
| Q48146706 | Genomic sequences of two novel HLA-C alleles, HLA-C*15:143 and HLA-C*07:109:02. |
| Q90206558 | Germline-Encoded TCR-MHC Contacts Promote TCR V Gene Bias in Umbilical Cord Blood T Cell Repertoire |
| Q30846768 | Gorilla MHC class I gene and sequence variation in a comparative context |
| Q92377968 | Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype |
| Q47637069 | Graphtyper enables population-scale genotyping using pangenome graphs. |
| Q31039365 | HAPCAD: An open-source tool to detect PCR crossovers in next-generation sequencing generated HLA data |
| Q48094690 | HFE gene polymorphism defined by sequence-based typing of the Brazilian population and a standardized nomenclature for HFE allele sequences. |
| Q35742269 | HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02. |
| Q92360535 | HLA Haplotype Frequencies and Genetic Profiles of the Kuwaiti Population |
| Q36788683 | HLA Haplotype Validator for quality assessments of HLA typing. |
| Q50247563 | HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction |
| Q91936179 | HLA Matching in Unrelated Stem Cell Transplantation up to Date |
| Q35643999 | HLA Typing for the Next Generation |
| Q61480154 | HLA and KIR Associations of Cervical Neoplasia |
| Q91393861 | HLA and kidney disease: from associations to mechanisms |
| Q89425395 | HLA and lung transplantation |
| Q92052787 | HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications |
| Q27324007 | HLA class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection |
| Q38683065 | HLA class Ib in pregnancy and pregnancy-related disorders |
| Q36103962 | HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods |
| Q38757309 | HLA genotyping using the Illumina HLA TruSight next-generation sequencing kits: A comparison. |
| Q88636896 | HLA haplotype in association with the low incidence C*07:66 allele found by case analysis of Taiwanese and mainland Chinese individuals |
| Q36258287 | HLA supertype variation across populations: new insights into the role of natural selection in the evolution of HLA-A and HLA-B polymorphisms |
| Q64111919 | HLA*LA - HLA typing from linearly projected graph alignments |
| Q47907172 | HLA-A locus allelic dropout in Sanger sequence-based typing due to the single nucleotide polymorphism of exon 1. |
| Q48160839 | HLA-A*02:687, a novel allele identified by sequence-based typing in cord blood from a Korean woman. |
| Q52944057 | HLA-A*11:134, a novel HLA-A*11 variant, identified by sequence-based typing in a Taiwanese individual. |
| Q48349986 | HLA-A*24:02:01:09, a new allele identified by sequence-based typing in a Korean individual. |
| Q48265496 | HLA-A*24:388N: a novel HLA-A*24 allele identified by sequence-based typing. |
| Q64090468 | HLA-A*29:01-B*07:05-C*15:29*DRB1*10:01-DQB1*05:01, a deduced probable human leukocyte antigen haplotype in association with a human leukocyte antigen-C low-incidence allele C*15:29 in Taiwanese individuals |
| Q48199491 | HLA-A*30:125 shows a new antigen binding domain created from HLA-A*30:01 and HLA-A*30:02. |
| Q48168179 | HLA-A*33:74N, a novel HLA-A*33 variant, identified by sequence-based typing in a Taiwanese individual. |
| Q47331542 | HLA-A, -B and -DRB1 allele and haplotype frequencies of 8333 Chinese Han from the Zhejiang province, China |
| Q40057868 | HLA-A, -B, -C, -DR, and -DQ Matching in Pancreas Transplantation: Effect on Graft Rejection and Survival. |
| Q90695782 | HLA-A, -B, -C, -DRB1, -DQA1, and -DQB1 allele and haplotype frequencies defined by next generation sequencing in a population of East Croatia blood donors |
| Q61807007 | HLA-B and HLA-C Differ in Their Nanoscale Organization at Cell Surfaces |
| Q38560231 | HLA-B polymorphisms and intracellular assembly modes. |
| Q48093187 | HLA-B*40:01:45, a novel variant of HLA-B*40:01, discovered in a Taiwanese hematopoitic stem cell donor |
| Q48313544 | HLA-B*40:247, a novel HLA-B*40 variant, identified by sequence-based typing in a Taiwanese individual |
| Q48104725 | HLA-B*40:302, a novel allele identified by sequence-based typing in a Korean individual. |
| Q50246482 | HLA-B*67:01:03, a HLA novel allele, identified in a Chinese platelet donor |
| Q38849274 | HLA-B27 Anterior Uveitis: Immunology and Immunopathology |
| Q58586444 | HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome |
| Q33785744 | HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy |
| Q37480654 | HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region. |
| Q39455571 | HLA-C*06:04:02 a novel HLA-C allele isolated from donors of Southern African descent |
| Q48290889 | HLA-DPB1*518:01, a new allele identified by sequence-based typing in a Korean individual. |
| Q48290829 | HLA-DPB1*519:01, a new allele identified by sequence-based typing in a Korean individual |
| Q37646908 | HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells |
| Q48308229 | HLA-DQB1*02:102, a novel allele identified by next-generation sequencing in a Spanish individual. |
| Q53666135 | HLA-DQB1*03:01:34, a novel allele, which has arisen by silent mutation in codon 87. |
| Q40629322 | HLA-DQB1*05:10, a variant of HLA-DQB1*05:01, detected in a Chinese individual by cloning and sequencing |
| Q48204139 | HLA-DQB1*05:144, a novel allele, discovered in a Southeast Asian donor for stem cell transplantation. |
| Q52575302 | HLA-DQβ1 amino acid position 87 and DQB1*0301 are associated with Chinese Han SLE. |
| Q40607323 | HLA-DRB1 the notorious gene in the mosaic of autoimmunity |
| Q48315249 | HLA-DRB3*02:61Q , a novel HLA-DRB3 allele identified in a volunteer bone marrow donor. |
| Q65001460 | HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues. |
| Q54258289 | HLA-G Haplotypes Are Differentially Associated with Asthmatic Features. |
| Q53076346 | HLA-G peptide preferences change in transformed cells: impact on the binding motif. |
| Q89495007 | HLA-H: Transcriptional Activity and HLA-E Mobilization |
| Q36350030 | HLA-HD: An accurate HLA typing algorithm for next-generation sequencing data. |
| Q36320407 | HLA-MA: Simple yet powerful matching of samples using HLA typing results. |
| Q93029319 | HLA-VBSeq v2: improved HLA calling accuracy with full-length Japanese class-I panel |
| Q33892400 | HLA-check: evaluating HLA data from SNP information |
| Q42063952 | HLAProfiler utilizes k-mer profiles to improve HLA calling accuracy for rare and common alleles in RNA-seq data. |
| Q47320133 | HLAs: Key regulators of T-cell-mediated drug hypersensitivity. |
| Q33667885 | HLAscan: genotyping of the HLA region using next-generation sequencing data |
| Q36053619 | HLAsupE: an integrated database of HLA supertype-specific epitopes to aid in the development of vaccines with broad coverage of the human population. |
| Q33743205 | Hapl-o-Mat: open-source software for HLA haplotype frequency estimation from ambiguous and heterogeneous data |
| Q40598552 | Haplotyping the human leukocyte antigen system from single chromosomes. |
| Q37342417 | Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1. |
| Q47239332 | High Molecular Weight DNA Enrichment with Peptide Nucleic Acid Probes. |
| Q37722457 | High resolution HLA haplotyping by imputation for a British population bioresource |
| Q90176832 | High-Throughput MICA/B Genotyping of Over Two Million Samples: Workflow and Allele Frequencies |
| Q99711638 | High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis |
| Q92808532 | High-resolution analysis of the HLA-A, -B, -C and -DRB1 alleles and national and regional haplotype frequencies based on 120 926 volunteers from the Italian Bone Marrow Donor Registry |
| Q47563253 | High-sensitivity HLA typing by Saturated Tiling Capture Sequencing (STC-Seq). |
| Q38983113 | High-throughput next-generation sequencing to genotype six classical HLA loci from 96 donors in a single MiSeq run. |
| Q38953773 | Human Birth Weight and Reproductive Immunology: Testing for Interactions between Maternal and Offspring KIR and HLA-C Genes |
| Q40097257 | Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? |
| Q26782686 | Human Leukocyte Antigen Diversity: A Southern African Perspective |
| Q48112929 | Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. |
| Q55116544 | Human Leukocyte Antigen-A, B, C, DRB1, and DQB1 Allele and Haplotype Frequencies in a Subset of 237 Donors in the South African Bone Marrow Registry. |
| Q66679937 | Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C |
| Q58697400 | Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity |
| Q90613623 | Human cytomegalovirus-vectored vaccines against HIV |
| Q30238992 | Human leucocyte antigen-adverse drug reaction associations: from a perspective of ethnicity. |
| Q26741035 | Human leukocyte Antigen-DM polymorphisms in autoimmune diseases |
| Q103044914 | Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression |
| Q37304135 | Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research |
| Q61452096 | Human leukocyte antigen-A*33:03-B*58:01-DRB1*15:140, a deduced probable human leukocyte antigen haplotype in association with a human leukocyte antigen low-incidence allele DRB1*15:140 in Taiwanese individuals: A case analysis |
| Q51221776 | Identification and characterization a novel HLA-A allele, A*02:355, by sequence-based typing in a Chinese potential donor. |
| Q53404499 | Identification of 2 novel HLA-B alleles, HLA-B*55:02:09 and HLA-B*55:80 in Chinese individuals. |
| Q48266912 | Identification of 400 novel alleles at the HLA-A, -B, -C, -DRB1, -DQB1 loci from China Marrow Donor Program. |
| Q40445305 | Identification of DPB1*581:01, a novel HLA-DPB1 allele in a Chinese Mongolian individual |
| Q48104682 | Identification of HLA-B*58:01:21, a novel allele in a Korean individual |
| Q40711668 | Identification of a new HLA-B*27 allele, B*27:133, in a Russian individual |
| Q53094391 | Identification of a new HLA-B*51:226 allele in a Chinese bone marrow-related donor. |
| Q48260355 | Identification of a new HLA-DQB1*06 allele, HLA-DQB1*06:210, by monoallelic Sanger sequencing |
| Q51713267 | Identification of a new HLA-G allele, HLA-G*01:19, by cloning and phasing. |
| Q48111947 | Identification of a novel HLA allele, HLA-B*15:416, in a bone marrow hematopoietic stem cell donor |
| Q48138937 | Identification of a novel HLA allele, HLA-B*41:50, in a French individual. |
| Q40721340 | Identification of a novel HLA-A allele, A*11:209 by sequence-based high-resolution typing in an HIV-infected individual |
| Q48318755 | Identification of a novel HLA-A allele, HLA-A*02:505, by sequence-based typing in a patient with tuberculosis. |
| Q54542078 | Identification of a novel HLA-A allele, HLA-A*02:590, in a Korean individual. |
| Q40290131 | Identification of a novel HLA-A*02:06:01:02 allele in a Chinese individual by sequence-based typing |
| Q48115600 | Identification of a novel HLA-B allele, HLA-B*40:238, in a Taiwanese individual. |
| Q48279939 | Identification of a novel HLA-B allele, HLA-B*55:81. |
| Q52850298 | Identification of a novel HLA-B null allele, HLA-B*41:45N, by HLA typing of two related Caucasoid individuals. |
| Q48274351 | Identification of a novel HLA-B*13 allele, HLA-B*13:99, by sequence-based typing in German bone marrow donor. |
| Q38420968 | Identification of a novel HLA-B*15 variant, B*15:367, using sequence-based typing in a Korean woman |
| Q48121160 | Identification of a novel HLA-B*18 allele, B*18:119, using sequence-based typing in a caucasoid individual. |
| Q48093238 | Identification of a novel HLA-B*27 variant, B*27:112, by sequence-based typing in a Taiwanese donor. |
| Q48336414 | Identification of a novel HLA-B*40 allele, HLA-B*40:332, in a Korean individual. |
| Q40689527 | Identification of a novel HLA-B*40 variant allele, B*40:301, by sequence-based typing |
| Q40379048 | Identification of a novel HLA-C*03 variant allele, C*03:280 by sequence-based typing |
| Q48361274 | Identification of a novel HLA-C*08 allele, HLA-C*08:01:20. |
| Q40612452 | Identification of a novel HLA-C*15 allele, HLA-C*15:96Q. |
| Q54144271 | Identification of a novel HLA-DRB1*14 allele, HLA-DRB1*14:127:01, in a Chinese Individual. |
| Q48168118 | Identification of a novel allele, HLA-A*02:01:131, by full-length genomic sequencing |
| Q50099344 | Identification of a novel allele, HLA-A*02:189, in a Chinese Han individual |
| Q48324769 | Identification of a novel allele, HLA-A*03:289, by sequence-based typing in Lithuanian patient |
| Q54141873 | Identification of a novel allele, HLA-A*26:01:01:03N, by full-length genome sequencing. |
| Q48105326 | Identification of a novel allele, HLA-B*15:01:23, in a platelet donor by sequence-based typing |
| Q48126471 | Identification of a novel allele, HLA-C*01:135, by full-length genomic sequencing. |
| Q48094825 | Identification of a novel allele, HLA-C*02:02:33, by full-length genomic sequencing |
| Q40528411 | Identification of a novel allele: DQB1*06:127 in Hispanic sisters. |
| Q90493893 | Identification of a tumor-specific allo-HLA-restricted γδTCR |
| Q57139711 | Identification of novel HIV-1-derived HLA-E-binding peptides |
| Q52564921 | Identification of novel therapeutic candidates in Cryptosporidium parvum: an in silico approach. |
| Q29048598 | Identification of the core regulators of the HLA I-peptide binding process |
| Q48290574 | Identification of the new C*07:555 allele in an unrelated donor for HSCT. |
| Q48359774 | Identification of the new HLA-DQA1*01:15N allele in an Italian patient. |
| Q48187584 | Identification of the new HLA-DRB1*14:186 allele in an Italian bone marrow donor |
| Q54572130 | Identification of the novel B*27:144 allele in an Irish Individual. |
| Q48176695 | Identification of the novel HLA-A*11:141 allele in a Chinese bone marrow donor |
| Q47338092 | Identification of the novel HLA-B*07:261 allele. |
| Q53507879 | Identification of the novel HLA-B*13:83 allele by polymerase chain reaction sequence-based typing in a Chinese cord blood donor. |
| Q48199544 | Identification of the novel HLA-B*27:04:06 allele in a Chinese bone marrow donor |
| Q53346024 | Identification of the novel HLA-B*27:147 allele by polymerase chain reaction sequence-based typing. |
| Q48336439 | Identification of the novel HLA-B*39:01:01:04 allele in a Chinese individual by sequence-based typing |
| Q53383443 | Identification of the novel HLA-B*40:01:41 allele by polymerase chain reaction sequence-based typing in a Chinese cord blood donor. |
| Q53474402 | Identification of the novel HLA-B*52:01:27 allele by polymerase chain reaction sequence-based typing. |
| Q48187002 | Identification of the novel HLA-B*57:91 allele, by next-generation sequencing in a Spanish individual. |
| Q48193588 | Identification of the novel HLA-DQB1*02:85 and HLA-DRB1*01:01:30 alleles in Russian individuals. |
| Q48152861 | Identification of the novel HLA-DQB1*03:181 allele in a Chinese leukemia patient. |
| Q53663132 | Identification of the novel HLA-DRB1*08:69 allele by polymerase chain reaction sequence-based typing in a Chinese cord blood donor. |
| Q53367304 | Identification of the novel HLA-DRB1*15:127 allele by polymerase chain reaction sequence-based typing in a Chinese bone marrow donor. |
| Q48274727 | Identification of the novel allele, HLA-A*02:653, in an Italian patient. |
| Q48239600 | Identification of the novel allele, HLA-DRB1*09:30, by sequence-based high resolution typing. |
| Q53481619 | Identification of the novel null allele, HLA-C*01:109N, using polymerase chain reaction sequence-based typing in a Chinese leukemia patient. |
| Q48253894 | Identification of two new HLA class I alleles in Italian bone marrow donors: A*31:125 and B*44:269. |
| Q53161837 | Identification of two novel HLA-A alleles, HLA-A*03:181 and HLA-A*03:229 in Chinese individuals. |
| Q52973861 | Identification of two novel HLA-DQB1 alleles, HLA-DQB1*03:164 and HLA-DQB1*03:165 in Chinese individuals. |
| Q58549354 | Immune diversity sheds light on missing variation in worldwide genetic diversity panels |
| Q63728479 | Immunity and mental illness: findings from a Danish population-based immunogenetic study of seven psychiatric and neurodevelopmental disorders |
| Q47011252 | Immunogenetic Factors in Early Immune Control of Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Evaluation of HLA Class I Amino Acid Variants in Two African Populations |
| Q89605734 | Immunogenetics in stem cell donor registry work: The DKMS example (Part 2) |
| Q91636268 | Immunogenicity and Immune Silence in Human Cancer |
| Q36304147 | Immunoinformatics and epitope prediction in the age of genomic medicine |
| Q39638026 | Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching? |
| Q49483662 | Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens |
| Q89455203 | Immunothérapie et greffe de cellules souches hématopoïétiques allogéniques |
| Q36255385 | Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study |
| Q37260631 | Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. |
| Q90061122 | In silico epitope prediction and immunogenic analysis for penton base epitope-focused vaccine against hydropericardium syndrome in chicken |
| Q90450871 | In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance |
| Q35872389 | Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01. |
| Q92024462 | Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania |
| Q52324550 | Intragenic transcriptional interference regulates the human immune ligand MICA. |
| Q57805467 | Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules |
| Q39455581 | Isolation of full-length HLA-C*18:02 allele in an individual from Sub-Saharan Africa |
| Q92001070 | KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors |
| Q36094774 | KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease. |
| Q36748102 | KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles. |
| Q38849746 | KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans |
| Q37021151 | Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients |
| Q64947307 | Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. |
| Q36863181 | Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition |
| Q50130961 | Kourami: graph-guided assembly for novel human leukocyte antigen allele discovery |
| Q26738439 | Leukocyte Ig-Like Receptors - A Model for MHC Class I Disease Associations |
| Q50285341 | Limited HLA sequence variation outside of antigen recognition domain exons of 360 10 of 10 matched unrelated hematopoietic stem cell transplant donor-recipient pairs |
| Q38721695 | Limited MHC class I intron 2 repertoire variation in bonobos |
| Q40460810 | Low Constitutive Cell Surface Expression of HLA-B Is Caused by a Posttranslational Mechanism Involving Glu180 and Arg239. |
| Q46933088 | MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic |
| Q38635387 | MHC matching improves engraftment of iPSC-derived neurons in non-human primates |
| Q46916619 | MHC-I Genotype Restricts the Oncogenic Mutational Landscape |
| Q40768509 | MICA*A4 protects against ulcerative colitis, whereas MICA*A5.1 is associated with abscess formation and age of onset |
| Q91671018 | Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors |
| Q52374806 | Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism. |
| Q38947679 | Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction |
| Q53523063 | Men's preferences for women's body odours are not associated with human leucocyte antigen. |
| Q55317822 | Meta-populational demes constitute a reservoir for large MHC allele diversity in wild house mice (Mus musculus). |
| Q26744637 | MinION: A Novel Tool for Predicting Drug Hypersensitivity? |
| Q40454552 | Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. |
| Q47613223 | Modeling coverage gaps in haplotype frequencies via Bayesian inference to improve stem cell donor selection |
| Q91655154 | Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection |
| Q55037801 | Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island Samples |
| Q38788557 | NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors. |
| Q46722989 | Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection |
| Q36742441 | NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets |
| Q48305245 | New insights in HLA-E polymorphism by refined analysis of the full-length gene. |
| Q58556154 | Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis |
| Q92192654 | Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop |
| Q48519025 | Nomenclature and Serology of HLA Class I and Class II Alleles |
| Q40668845 | Nomenclature for factors of the HLA system, update April 2015. |
| Q48579900 | Nomenclature for factors of the HLA system, update April 2015. |
| Q47861953 | Nomenclature for factors of the HLA system, update April 2016. |
| Q48573092 | Nomenclature for factors of the HLA system, update August 2015. |
| Q48545138 | Nomenclature for factors of the HLA system, update August 2016. |
| Q47808038 | Nomenclature for factors of the HLA system, update August 2017. |
| Q48509670 | Nomenclature for factors of the HLA system, update August 2017. |
| Q48566145 | Nomenclature for factors of the HLA system, update December 2015. |
| Q47841110 | Nomenclature for factors of the HLA system, update December 2016. |
| Q47874055 | Nomenclature for factors of the HLA system, update February 2016. |
| Q48552037 | Nomenclature for factors of the HLA system, update February 2016. |
| Q47874064 | Nomenclature for factors of the HLA system, update January 2016. |
| Q48552056 | Nomenclature for factors of the HLA system, update January 2016. |
| Q48573105 | Nomenclature for factors of the HLA system, update July 2015. |
| Q47849759 | Nomenclature for factors of the HLA system, update July 2016. |
| Q47808373 | Nomenclature for factors of the HLA system, update July 2017. |
| Q48509689 | Nomenclature for factors of the HLA system, update July 2017. |
| Q40663850 | Nomenclature for factors of the HLA system, update June 2015. |
| Q48579881 | Nomenclature for factors of the HLA system, update June 2015. |
| Q47862058 | Nomenclature for factors of the HLA system, update June 2016. |
| Q47874024 | Nomenclature for factors of the HLA system, update March 2016. |
| Q48552020 | Nomenclature for factors of the HLA system, update March 2016. |
| Q40668717 | Nomenclature for factors of the HLA system, update May 2015. |
| Q48579892 | Nomenclature for factors of the HLA system, update May 2015. |
| Q47861974 | Nomenclature for factors of the HLA system, update May 2016. |
| Q48566151 | Nomenclature for factors of the HLA system, update November 2015. |
| Q47840837 | Nomenclature for factors of the HLA system, update November 2016. |
| Q48566164 | Nomenclature for factors of the HLA system, update October 2015. |
| Q47840949 | Nomenclature for factors of the HLA system, update October 2016. |
| Q48573080 | Nomenclature for factors of the HLA system, update September 2015. |
| Q47849777 | Nomenclature for factors of the HLA system, update September 2016. |
| Q47808356 | Nomenclature for factors of the HLA system, update September 2017. |
| Q48509680 | Nomenclature for factors of the HLA system, update September 2017. |
| Q92498132 | Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients |
| Q38789472 | Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics |
| Q90704538 | Optimal Donor Selection During Verification Process: Which Factors Are Worth Knowing? |
| Q58707974 | Pan-cancer analysis of neoepitopes |
| Q64238457 | Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations |
| Q38793923 | Patterns of MHC-dependent mate selection in humans and nonhuman primates: a meta-analysis. |
| Q52735702 | Pedigree-Defined Haplotypes and Their Applications to Genetic Studies. |
| Q55605287 | Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance. |
| Q47654607 | Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation |
| Q89882645 | Pleasant body odours, but not genetic similarity, influence trustworthiness in a modified trust game |
| Q94528313 | Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor |
| Q48361316 | Polymorphism at residue 156 of the new HLA-A*02:683 allele suggests immunological relevance. |
| Q58577938 | Population genomics of parallel evolution in gene expression and gene sequence during ecological adaptation |
| Q90172624 | Predictive in silico binding algorithms reveal HLA specificities and autoallergen peptides associated with atopic dermatitis |
| Q88797034 | Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection |
| Q36014017 | Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study |
| Q90262496 | Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantation |
| Q40336966 | Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07. |
| Q92642094 | Rapid Detection of HLA-B*57:01-Expressing Cells Using a Label-Free Interdigitated Electrode Biosensor Platform for Prevention of Abacavir Hypersensitivity in HIV Treatment |
| Q51612567 | Rapid and reliable genotyping of HLA-B*58:01 in four Chinese populations using a single-tube duplex real-time PCR assay. |
| Q53774241 | Recognition of a novel HLA-DRB1*09 variant, HLA-DRB1*09:25, in a Taiwanese hematopoietic stem cell donor. |
| Q91625804 | Regulatory T cells and co-evolution of allele-specific MHC recognition by the TCR |
| Q31032633 | Reproducibility and conflicts in immune epitope data |
| Q52338453 | Restricted MHC class I A locus diversity in olive and hybrid olive/yellow baboons from the Southwest National Primate Research Center. |
| Q48311471 | Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C. |
| Q40189657 | Revealing complete complex KIR haplotypes phased by long-read sequencing technology |
| Q91026484 | Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study |
| Q92783100 | SLA-1 Genetic Diversity in Pigs: Extensive Analysis of Copy Number Variation, Heterozygosity, Expression, and Breed Specificity |
| Q47210897 | Saddlebags: A software interface for submitting full-length HLA allele sequences to the EMBL-ENA nucleotide database |
| Q91774665 | Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR |
| Q38558820 | Sensitization assessment before kidney transplantation |
| Q38985750 | Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes |
| Q40630646 | Sequence conservation predicts T cell reactivity against ragweed allergens |
| Q38379298 | Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya |
| Q46081837 | Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 339 adults from Managua, Nicaragua |
| Q57064986 | Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USA |
| Q47229904 | Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 714 adults from Colombo, Sri Lanka |
| Q40643475 | Sequence-based typing characterization of the novel HLA-DRB3*01:16 allele, identified in an Italian family |
| Q48138551 | Sequence-based typing identification of the novel HLA-C*07:565 variant in a Chinese family. |
| Q48171512 | Sequence-based typing of a novel HLA-DRB1 allele, HLA-DRB1*14:32:03, in a Chinese individual |
| Q38737497 | Sequences of 95 human MHC haplotypes reveal extreme coding variation in genes other than highly polymorphic HLA class I and II. |
| Q48152704 | Sequencing of the novel HLA-A*02:01:72 allele in a Chinese hematopoietic stem cell donor. |
| Q27312114 | Signature Patterns of MHC Diversity in Three Gombe Communities of Wild Chimpanzees Reflect Fitness in Reproduction and Immune Defense against SIVcpz |
| Q33440638 | Simultaneous human platelet antigen genotyping and detection of novel single nucleotide polymorphisms by targeted next-generation sequencing |
| Q48240208 | Single molecule real-time DNA sequencing of HLA genes at ultra-high resolution from 126 International HLA and Immunogenetics Workshop cell lines. |
| Q59068540 | Single-cell reconstruction of the early maternal–fetal interface in humans |
| Q46257343 | Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens. |
| Q58741787 | Spatial analyzes of HLA data in Rio Grande do Sul, south Brazil: genetic structure and possible correlation with autoimmune diseases |
| Q33851012 | Structural and regulatory diversity shape HLA-C protein expression levels |
| Q59813602 | Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach |
| Q92651121 | Structure and Function of Molecular Chaperones that Govern Immune Peptide Loading |
| Q64066337 | Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells |
| Q56535000 | Systems Immunology: Learning the Rules of the Immune System |
| Q42381250 | T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire. |
| Q92525198 | T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes |
| Q94474376 | Targeted analysis of polymorphic loci from low-coverage shotgun sequence data allows accurate genotyping of HLA genes in historical human populations |
| Q41827687 | TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates |
| Q53126060 | The 24th annual Nucleic Acids Research database issue: a look back and upcoming changes. |
| Q33737477 | The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype |
| Q48093513 | The DRB1*15:11 allele discovered in a Taiwanese unrelated hematopoietic stem cell donor. |
| Q93046804 | The EMBL-EBI search and sequence analysis tools APIs in 2019 |
| Q89790289 | The HLA-A03 supertype and several Pan species' MHC-A allotypes share a preference for binding positively charged residues in the F pocket: implications for controlling retroviral infections |
| Q41994001 | The HLA-B landscape of Africa: signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protection |
| Q48237827 | The HLA-C*05 family allele - C*05:142. |
| Q42317060 | The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA. |
| Q52611086 | The Rare Disease Bank of Japan: establishment, current status and future challenges. |
| Q38370910 | The T cell antigen receptor: the Swiss army knife of the immune system. |
| Q64115110 | The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance |
| Q99588217 | The deduced probable HLA-C*03:187-associated human leukocyte antigen haplotype (A*24:02-B*35:01-C*03:187-DRB1*11:01) revealed in Taiwanese unrelated hematopoietic bone marrow stem cell donors |
| Q36431461 | The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch |
| Q40291314 | The full length genomic sequence of a novel HLA-A*24 allele, HLA-A*24:353, identified in a patient with hepatitis B infection. |
| Q48108502 | The full-length sequence of HLA-B*59:01:01:01 confirmed by cloning and sequencing |
| Q90123573 | The impact of KIR/HLA genes on the risk of developing multibacillary leprosy |
| Q93092586 | The microstructure in the placenta is influenced by the functional diversity of HLA-G allelic variants |
| Q40057783 | The new HLA-A*24:321 shows one conservative amino acid replacement compared with HLA-A*24:02:01. |
| Q48287213 | The new HLA-B*50:51 allele was generated by intralocus recombination between B*50:01:01:02 and B*14:02:01. |
| Q48152582 | The novel HLA-A*24:02 variant, HLA-A*24:02:56, identified by sequencing in a Chinese individual. |
| Q54145419 | The novel HLA-B allele, HLA-B*15:226N, was identified by sequencing genomic DNA in a platelet donor. |
| Q48240220 | The novel HLA-B*08:183 allele identified by sequence-based typing in a Caucasian leukemia patient. |
| Q40866570 | The novel HLA-B*44 allele, HLA-B*44:220, identified by Single Molecule Real-Time DNA sequencing in a British Caucasoid male. |
| Q50226939 | The novel HLA-C*15:103 is characterised by an amino acid substitution in the alpha 2 domain |
| Q50075258 | The novel allele, HLA-A*24:383, was identified in a Chinese individual by sequence-based typing |
| Q48186973 | The novel allele, HLA-A*31:108, identified by sequence-based typing in a Chinese individual. |
| Q48324837 | The novel null allele, HLA-B*40:338N, was identified in a Chinese leukemia patient |
| Q46472738 | The orthologs of HLA-DQ and -DP genes display abundant levels of variability in macaque species |
| Q64237733 | The phylogeny of 48 alleles, experimentally verified at 21 kb, and its application to clinical allele detection |
| Q58724946 | The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection |
| Q58760140 | The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression |
| Q39427540 | The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions |
| Q38752224 | The role of gene polymorphism in HLA class I splicing |
| Q47190955 | The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction |
| Q52955086 | The ultimate mix and match: making sense of HLA alleles and peptide repertoires. |
| Q39892714 | Thinking differently about lupus. |
| Q48214955 | Three new HLA alleles-B*49:43, C*03:321 and DQB1*02:72. |
| Q48138472 | Three new HLA class I alleles with synonymous mutations: HLA-A*03:01:62, -C*07:02:82 and -C*12:03:42. |
| Q91869570 | Towards a gamete matching platform: using immunogenetics and artificial intelligence to predict recurrent miscarriage |
| Q55234148 | Transfusion Medicine and Molecular Genetic Methods. |
| Q41673077 | Transmembrane Helices Are an Overlooked Source of Major Histocompatibility Complex Class I Epitopes |
| Q39175303 | Transplant genetics and genomics |
| Q28082704 | Tumor neoantigens: building a framework for personalized cancer immunotherapy |
| Q48198932 | Two new HLA class I alleles described in a Spanish individual, HLA-A*11:01:01:04 and HLA-B*35:330. |
| Q54772340 | Two new HLA-B35 subtypes characterized in Spaniards: HLA-B*35:270 and HLA-B*35:273. |
| Q48300477 | Two novel alleles, HLA-A*02:643N and HLA-B*53:44, identified in Brazilian individuals. |
| Q64228645 | Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC |
| Q92031534 | TypeLoader2: Automated submission of novel HLA and killer-cell immunoglobulin-like receptor alleles in full length |
| Q38374452 | TypeLoader: A fast and efficient automated workflow for the annotation and submission of novel full-length HLA alleles. |
| Q31158604 | Typing and copy number determination for HLA-DRB3, -DRB4 and -DRB5 from next-generation sequencing data. |
| Q61800776 | Understanding HLA associations from SNP summary association statistics |
| Q38804389 | Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes |
| Q40048119 | Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices |
| Q88636996 | Using high-resolution human leukocyte antigen typing of 11,423 randomized unrelated individuals to determine allelic varieties, deduce probable human leukocyte antigen haplotypes, and observe linkage disequilibria between human leukocyte antigen-B a |
| Q33594882 | Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice |
| Q88581857 | VDJ Gene Usage of B Cell Receptors in Peripheral Blood of ABO-incompatible Kidney Transplantation Patients |
| Q47145127 | VDJ gene usage among B-cell receptors in ABO-incompatible kidney transplantation determined by RNA-seq Transcriptomic analysis |
| Q91967420 | Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8+ T Cells in Nonhuman Primates |
| Q55545340 | Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity. |
| Q35967750 | Very long haplotype tracts characterized at high resolution from HLA homozygous cell lines |
| Q92983618 | Vive la difference! Self/non-self recognition and the evolution of signatures of identity in arms races with parasites |
| Q92581297 | arcasHLA: high-resolution HLA typing from RNAseq |
| Q31019458 | iWAS--A novel approach to analyzing Next Generation Sequence data for immunology |
| Q41433006 | β2-microglobulin gene duplication in cetartiodactyla remains intact only in pigs and possibly confers selective advantage to the species |
Search more.